دورية أكاديمية
أعرض في EDS

Meta-Analysis of Pharmacological, Nutraceutical and Phytopharmaceutical Interventions for the Treatment of Cancer Related Fatigue.

التفاصيل البيبلوغرافية
العنوان: Meta-Analysis of Pharmacological, Nutraceutical and Phytopharmaceutical Interventions for the Treatment of Cancer Related Fatigue.
المؤلفون: Yennurajalingam S; Department of Palliative Care Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lu Z; Department of Palliative Care Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rozman De Moraes A; Department of Palliative Care Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tull NN; Department of Palliative Care Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kubiak MJ; Department of Palliative Care Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Geng Y; Research Medical Library, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Andersen CR; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bruera E; Department of Palliative Care Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
المصدر: Cancers [Cancers (Basel)] 2022 Dec 23; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 23.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مستخلص: Purpose: In this study we aimed to estimate the effectiveness of pharmacological, nutraceutical, and phytopharmaceutical treatments on CRF. Methods: Ovid MEDLINE, Ovid Embase, Ovid Psych info, CINHAHL and Cochrane Library databases were searched up to 30 September 2021. Randomized controlled trials of pharmacological, nutraceutical and phytopharmaceutical interventions for treatment of CRF for at least one week duration and have used valid tool to assess severity of CRF as a primary or secondary outcome were considered. Results: 32 eligible studies (4896 patients) were reviewed. For the overall meta-analysis, the random effect models yielded the treatment effect (95% CI) of −0.29 (−0.48,−0.09), p < 0.001. The meta-analysis did not show significant reduction of CRF with treatment with ginseng (n = 6), guarana (n = 3), megestrol (n = 2), mistletoe (n = 3), psychostimulants (n = 14), SSRI/antidepressants (n = 2). Corticosteroids (n = 2) showed significant reduction in CRF with treatment effects of 0.94 (−1.21, −0.67), p <0.0001, respectively. Conclusions: In this study, overall meta-analysis of all studies demonstrates significant reduction of CRF using Pharmacological, Nutraceutical and Phytopharmaceutical interventions with a pooled standardized treatment effect of −0.29. Metanalysis of Corticosteroids studies showed significant reduction in CRF. Further studies are needed.
References: JAMA Oncol. 2017 Jul 01;3(7):961-968. (PMID: 28253393)
Integr Cancer Ther. 2021 Jan-Dec;20:1534735420988343. (PMID: 33543655)
J Natl Cancer Inst. 2013 Aug 21;105(16):1230-8. (PMID: 23853057)
Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1496-501. (PMID: 17869448)
Brain Behav Immun. 2006 Nov;20(6):546-51. (PMID: 16469481)
J Clin Oncol. 2013 Jul 1;31(19):2421-7. (PMID: 23690414)
J Nutr. 2007 Jan;137(1 Suppl):183S-185S. (PMID: 17182823)
Xenobiotica. 2018 Oct;48(10):973-983. (PMID: 29050522)
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1547-1551. (PMID: 29936730)
BMJ Support Palliat Care. 2021 Sep 30;:. (PMID: 34593386)
J Clin Oncol. 2003 Jan 1;21(1):129-34. (PMID: 12506181)
Neuro Oncol. 2015 Oct;17(10):1393-401. (PMID: 25972454)
J Pain Symptom Manage. 2009 Apr;37(4):613-21. (PMID: 18790598)
J Pain Symptom Manage. 2009 Apr;37(4):622-31. (PMID: 18809275)
Dtsch Arztebl Int. 2014 Jul 21;111(29-30):493-502, 33 p following 502. (PMID: 25142075)
J Clin Oncol. 2014 Jun 20;32(18):1882-8. (PMID: 24778393)
Breast Cancer Res Treat. 2018 Oct;171(3):515-526. (PMID: 29915949)
Curr Oncol. 2018 Apr;25(2):e152-e167. (PMID: 29719440)
J Clin Oncol. 2003 Dec 15;21(24):4635-41. (PMID: 14673053)
J Pain Symptom Manage. 2020 May;59(5):966-973. (PMID: 31668965)
Clin Invest Med. 2012 Feb 01;35(1):E1-11. (PMID: 22309959)
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):751-4. (PMID: 2410117)
Biol Psychiatry. 2006 Nov 15;60(10):1111-20. (PMID: 16806100)
Biochem Biophys Res Commun. 2002 Aug 16;296(2):247-54. (PMID: 12163009)
BMJ Support Palliat Care. 2020 Dec;10(4):385-394. (PMID: 32046962)
Nat Rev Clin Oncol. 2014 Oct;11(10):597-609. (PMID: 25113839)
Evid Based Ment Health. 2019 Nov;22(4):153-160. (PMID: 31563865)
Nutrients. 2017 Nov 07;9(11):. (PMID: 29112178)
Cancer. 2009 Sep 15;115(18 Suppl):4265-9. (PMID: 19731347)
Front Physiol. 2021 Oct 13;12:759280. (PMID: 34721081)
Appetite. 2008 Mar-May;50(2-3):506-13. (PMID: 18077056)
J Clin Oncol. 2006 May 1;24(13):2073-8. (PMID: 16648508)
Cancers (Basel). 2021 Feb 26;13(5):. (PMID: 33652866)
J Pain Symptom Manage. 2012 Dec;44(6):823-30. (PMID: 22795903)
J Ethnopharmacol. 2013 Oct 28;150(1):14-31. (PMID: 23981847)
Arh Hig Rada Toksikol. 2017 Dec 20;68(4):287-297. (PMID: 29337686)
Neuro Oncol. 2016 Jun;18(6):849-54. (PMID: 26902850)
Nutr Cancer. 2019;71(1):21-40. (PMID: 30688088)
J Palliat Med. 2007 Oct;10(5):1068-75. (PMID: 17985963)
Neuropsychiatr Dis Treat. 2007 Jun;3(3):349-64. (PMID: 19300566)
Clin Cancer Res. 2011 Oct 15;17(20):6373-80. (PMID: 21750199)
J Diet Suppl. 2013 Dec;10(4):325-34. (PMID: 24237188)
CNS Spectr. 2004 Jun;9(6 Suppl 4):23-31. (PMID: 15181382)
Nutr Cancer. 2021;73(8):1270-1281. (PMID: 32691627)
N Engl J Med. 2005 Oct 20;353(16):1711-23. (PMID: 16236742)
Support Care Cancer. 2015 Aug;23(8):2461-78. (PMID: 25975676)
Eur J Cancer. 1999 Apr;35(4):586-95. (PMID: 10492632)
J Pain Symptom Manage. 2011 Apr;41(4):761-7. (PMID: 21251796)
J Clin Oncol. 2014 Oct 10;32(29):3221-8. (PMID: 25002731)
Cancer. 2010 Jul 15;116(14):3513-20. (PMID: 20564068)
Clin Pharmacokinet. 1999 Dec;37(6):457-70. (PMID: 10628897)
Cancer. 1974 Jun;33(6):1607-9. (PMID: 4135151)
Oncology (Williston Park). 1998 Nov;12(11A):369-77. (PMID: 10028520)
Gynecol Oncol. 2015 Mar;136(3):446-52. (PMID: 25458588)
Integr Cancer Ther. 2013 Jul;12(4):312-22. (PMID: 23142798)
Mol Clin Oncol. 2018 Mar;8(3):413-416. (PMID: 29456846)
Oncologist. 2011;16(2):246-53. (PMID: 21282671)
Eur J Cancer Clin Oncol. 1989 Dec;25(12):1823-9. (PMID: 2483687)
J Cancer Res Clin Oncol. 2020 Oct;146(10):2479-2487. (PMID: 32617701)
Cancers (Basel). 2020 Sep 30;12(10):. (PMID: 33007977)
Eur J Cancer. 2020 May;130:51-62. (PMID: 32172198)
Breast Cancer (Auckl). 2009 Jul 06;3:35-45. (PMID: 21556248)
J Altern Complement Med. 2011 Jun;17(6):505-12. (PMID: 21612429)
Gulf J Oncolog. 2019 May;1(30):43-51. (PMID: 31242981)
J Clin Oncol. 2010 Aug 10;28(23):3673-9. (PMID: 20625123)
Sci Rep. 2021 Mar 12;11(1):5847. (PMID: 33712647)
Support Care Cancer. 2008 Jun;16(6):577-83. (PMID: 17972110)
JAMA. 2007 Jan 17;297(3):295-304. (PMID: 17227981)
BMJ Support Palliat Care. 2022 Jun;12(2):226-234. (PMID: 33168668)
J Natl Compr Canc Netw. 2017 Sep;15(9):1111-1120. (PMID: 28874596)
Oncologist. 2000;5(5):353-60. (PMID: 11040270)
J Clin Oncol. 2007 Nov 10;25(32):5128-32. (PMID: 17991932)
Compr Rev Food Sci Food Saf. 2022 Jan;21(1):272-295. (PMID: 34755935)
Evid Based Complement Alternat Med. 2019 Apr 17;2019:5893017. (PMID: 31118962)
Phys Ther. 2003 Aug;83(8):713-21. (PMID: 12882612)
Cells. 2019 Jul 18;8(7):. (PMID: 31323874)
Cancer Prev Control. 1998 Apr;2(2):74-8. (PMID: 9765767)
Cancer J. 2014 Sep-Oct;20(5):319-24. (PMID: 25299141)
Curr Oncol. 2022 Nov 01;29(11):8340-8356. (PMID: 36354718)
BMJ. 2011 Oct 18;343:d5928. (PMID: 22008217)
J Support Oncol. 2013 Mar;11(1):31-42. (PMID: 22682875)
J Altern Complement Med. 2009 Apr;15(4):431-3. (PMID: 19388866)
Oncol Nurs Forum. 2002 Aug;29(7):E85-90. (PMID: 12183762)
Support Care Cancer. 2012 Aug;20(8):1745-53. (PMID: 21947558)
Eur J Cancer Clin Oncol. 1989 Dec;25(12):1817-21. (PMID: 2698804)
Support Care Cancer. 2020 Apr;28(4):1755-1764. (PMID: 31302766)
Br J Cancer. 2014 Jul 8;111(1):33-45. (PMID: 24743705)
Ann Oncol. 2020 Jun;31(6):713-723. (PMID: 32173483)
Brain Behav Immun. 2019 Jul;79:24-38. (PMID: 30797959)
J Evid Based Complementary Altern Med. 2017 Jul;22(3):502-512. (PMID: 30208733)
Support Care Cancer. 2015 Jun;23(6):1503-12. (PMID: 25370889)
J Adv Pract Oncol. 2021 May;12(4):406-414. (PMID: 34123477)
J Clin Oncol. 2014 Jun 10;32(17):1840-50. (PMID: 24733803)
BMC Complement Med Ther. 2020 Jul 20;20(1):227. (PMID: 32690087)
Support Care Cancer. 2013 Sep;21(9):2599-607. (PMID: 23653013)
BMC Complement Altern Med. 2012 Oct 03;12:172. (PMID: 23033982)
J Natl Cancer Inst Monogr. 2004;(32):40-50. (PMID: 15263040)
Exp Neurol. 2003 Nov;184(1):521-9. (PMID: 14637121)
Eur J Cancer Care (Engl). 2016 Nov;25(6):970-979. (PMID: 26490083)
J Natl Compr Canc Netw. 2021 Dec 29;:1-9. (PMID: 34965510)
Nutrients. 2017 Jul 19;9(7):. (PMID: 28753932)
JNCI Cancer Spectr. 2019 Jun;3(2):pkz005. (PMID: 31119206)
Phytochemistry. 2014 Sep;105:25-36. (PMID: 24856135)
Ann Oncol. 2000 Aug;11(8):971-5. (PMID: 11038033)
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211038008. (PMID: 34369188)
NIH Consens State Sci Statements. 2002 Jul 15-17;19(4):1-29. (PMID: 14984106)
J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39. (PMID: 26285247)
Chin J Integr Med. 2017 May;23(5):331-337. (PMID: 26142337)
Curr Opin Oncol. 2010 Jul;22(4):307-11. (PMID: 20498598)
Support Care Cancer. 2014 May;22(5):1233-42. (PMID: 24337761)
J Clin Oncol. 2013 Sep 1;31(25):3076-82. (PMID: 23897970)
Cochrane Database Syst Rev. 2015 May 30;(5):CD006788. (PMID: 26026155)
Exp Neurol. 2002 Feb;173(2):224-34. (PMID: 11822886)
Clin Nutr. 2013 Jun;32(3):319-24. (PMID: 23395103)
Planta Med. 1989 Oct;55(5):429-33. (PMID: 2813579)
PLoS One. 2014 Jan 08;9(1):e84391. (PMID: 24416225)
J Clin Oncol. 2007 Aug 10;25(23):3475-81. (PMID: 17687152)
J Pain Symptom Manage. 2009 Nov;38(5):650-62. (PMID: 19896571)
Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):100-107. (PMID: 31627177)
معلومات مُعتمدة: P30 CA016672 United States CA NCI NIH HHS
فهرسة مساهمة: Keywords: cancer; fatigue; interventions; metanalysis; nutraceuticals; pharmacological; phytopharmaceuticals
تواريخ الأحداث: Date Created: 20230108 Latest Revision: 20230421
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9817820
DOI: 10.3390/cancers15010091
PMID: 36612088
قاعدة البيانات: MEDLINE
الوصف
تدمد:2072-6694
DOI:10.3390/cancers15010091